Max Wolf

Early therapeutic response assessment by 18FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure (2007)

Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...

Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients with diffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...

Early therapeutic response assessment by 18FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure (2007)

Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...

Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients with diffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...

Early therapeutic response assessment by 18FDG-positron emission tomography during chemotherapy in patients with diffuse large B-cell lymphoma: Isolated residual positivity involving bone is not usually a predictor of subsequent treatment failure (2007)

Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...

Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients with diffuse large B-cell lymphoma (DLBLC) prospectively identifies a...

Early therapeutic response assessment by 18FDG-positron emissiontomography during chemotherapy in patients with diffuse large B-celllymphoma: Isolated residual positivity involving bone is not usually apredictor of subsequent treatment failure (2007)

Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...

Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...

Early therapeutic response assessment by 18FDG-positron emissiontomography during chemotherapy in patients with diffuse large B-celllymphoma: Isolated residual positivity involving bone is not usually apredictor of subsequent treatment failure (2007)

Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...

Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...

Early therapeutic response assessment by 18FDG-positron emissiontomography during chemotherapy in patients with diffuse large B-celllymphoma: Isolated residual positivity involving bone is not usually apredictor of subsequent treatment failure (2007)

Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...

Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...

Early therapeutic response assessment by 18FDG-positron emissiontomography during chemotherapy in patients with diffuse large B-celllymphoma: Isolated residual positivity involving bone is not usually apredictor of subsequent treatment failure (2007)

Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...

Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...

Zur Effizienz des deutschen Gesundheitssystems (2004)

Wolf, Max

Gesundheitswesen

NEW FOODS FOR MILITARY USE. A PHYSICO-CHEMICAL APPROACH TO RESEARCH AND DEVELOPMENT, (1998)

Kapsalis,John G., Wolf,Max

Low and intermediate moisture foods have proved to be one of the most valuable of the various types of processed foods used in special combat feeding situations. One of the most complex problems that...

Über die bakteriostatische Wirkung der p-Aminobenzoesäure bei Staphylokokken und Streptokokken in vitro. (1952)

Wolf, Max.

Heidelberg, Med. F., Diss. v. 6. Mai 1952 (Nicht f. d. Aust.).

Über den Lückenschädel. (1942)

Wolf, Max.

Göttingen, Med. F., Diss., 1943 (Nicht f. d. Austausch).

Die Verkalkung und Verknöcherung der Kehlkopfknorpel beim Rot- und Rehwild / (1933)

Wolf, Max.

Thesis (doctoral)--Ludwig-Maximilians-Universität zu München, 1933.

Der Bundesstaatsgedanke in der schweizerischen Helvetik : der beginnende Einfluss der Vereinigten Staaten von Amerika auf die Schweiz / (1925)

Wolf, Max.

Katalogisiert nach einer xerogr. Reprod.

Der Bundesstaatsgedanke in der schweizerischen Helvetik - der beginnende Einfluss d. Ver. St. v. Amerika auf d. Schweiz. (1925)

Wolf, Max.

Ausz. in: Jahrbuch d. Diss. d. Phil. Fak. Berlin. 1924-25. I. - Dass. [Maschinenschrift] 84 S. 4

Die Rechtsstellung der Versicherungs-Generalagenten im geltenden und zukünftigen Rechte / (1923)

Wolf, Max.

Masch., n.f.d.A

Die Rechtsstellung der Versicherungs-Generalagenten im geltenden und zukünftigen Rechte / (1923)

Wolf, Max.

Mikrofiche-Ausg.: 2 Mikrofiches : 24x

Der Abholungsanspruch des [section] 867 BGB unter Berücksichtigung des Anspruches aus [section] 1005 BGB / (1912)

Wolf, Max.

Thesis (doctoral)--Universität Leipzig, 1912.

Orthostatische Symptome bei Purpura mit Tuberculose hereditär belasteter Kinder / (1907)

Wolf, Max.

Thesis (doctoral)--Universität Leipzig, 1907.

Die differentialgleichung der mittleren anomalie und die wahrscheinlichkeit der convergenz in der darstellung ihres integrals ... (1889)

Wolf, Max.

Inaug.-diss.--Heidelberg.

Ueber den Werth der künstlichen Frühgeburt bei engem Becken / (1886)

Wolf, Max.

Thesis (doctoral)--Rheinische Friedrich-Wilhelms-Universität zu Bonn, 1886.

Zur Effizienz des deutschen Gesundheitssystems

Max Wolf

In dieser Arbeit soll die Effizienz des deutschen Gesundheitswesens untersucht werden. Insbesondere werden im Hauptteil der Arbeit nach Krankheiten disaggregierte Input und Outputdaten des deutschen...

Zur Effizienz des deutschen Gesundheitssystems

Max Wolf

In dieser Arbeit soll die Effizienz des deutschen Gesundheitswesens untersucht werden. Insbesondere werden im Hauptteil der Arbeit nach Krankheiten disaggregierte Input und Outputdaten des deutschen...

Early therapeutic response assessment by 18FDG-positron emissiontomography during chemotherapy in patients with diffuse large B-celllymphoma: Isolated residual positivity involving bone is not usually apredictor of subsequent treatment failure

Ng, Dr. Ashley P., Wirth, Dr. Andrew, Seymour, Dr. John, Lee, Dr. Michael, Hogg, Dr. Annette, Januszewicz, Dr. Henry, ...

Residual 2-fluoro-2-deoxyglucose (FDG) – positron emission tomography (PET) positivity during treatment of patients withdiffuse large B-cell lymphoma (DLBLC) prospectively identifies a subgroup at...

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)

Mead, Graham M., Barrans, Sharon L., Qian, Wendi, Walewski, Jan, Radford, John A., Wolf, Max, ...

This prospective study aimed to develop reproducible diagnostic criteria for sporadic Burkitt lymphoma (BL), applicable to routine practice, and to evaluate the efficacy of dose-modified (dm)...

Evolutionary emergence of responsive and unresponsive personalities

Wolf, Max, Van Doorn, G. Sander, Weissing, Franz J.

In many animal species, individuals differ consistently in suites of correlated behaviors, comparable with human personalities. Increasing evidence suggests that one of the fundamental factors...